Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
amorolfine hydrochloride, Quantity: 55.7 mg/mL
Arrotex Pharmaceuticals Pty Ltd
amorolfine hydrochloride
Application
Excipient Ingredients: triacetin; ammonio methacrylate copolymer; ethanol; butyl acetate; ethyl acetate
Topical
5mL, 2.5mL
(S2) Pharmacy Medicine
For the treatment of onychomycoses caused by dermatophytes, yeasts and moulds.
Visual Identification: Clear liquid; Container Type: Bottle; Container Material: Glass Type III Coloured; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2013-04-08